A Switch Study of BMS-337039 in Schizophrenic Out-patients
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to evaluate the safety and tolerability of two
switching strategies from risperidone to aripiprazole over a period of 12 weeks in
out-patients who are treated in a general psychiatric practice setting and who are currently
experiencing efficacy and/or safety/tolerability issues while on risperidone.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.